EUVIMEDEUVIMED entdecken
Scoping ReviewOpen Access

A Scoping Review of Recent Evidence Relevant to the Oncology Nursing Society 2024–2027 Research Agenda

Jennifer Ross Majumdar, Tara A Albrecht, Sarah M Belcher, Marlee Clark, Meredith H Cummings, Claire Han, Lauri A Linder, Chinomso Nwozichi, Rosalynn Ofel Sanchez Ruiz, Lixin Song, Natalia Gondim Springer, Margaret Quinn Rosenzweig

Oncology Nursing Forum · 02.11.2026 · 53 (6)

DOI: 10.1188/26.onf.e26535396 ↗

Kurz gefasst

Scoping Review in der Zeitschrift Oncology Nursing Forum, online erschienen am 02.11.2026. Verfasst von Jennifer Ross Majumdar und 11 weiteren Autor:innen. Beteiligte Einrichtung: Jennifer Ross Majumdar. Hauptthemen laut MEDLINE: Oncology Nursing, Societies, Nursing, Nursing Research, Evidence-Based Nursing. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PROBLEM IDENTIFICATION: The Oncology Nursing Society 2024-2027 Research Agenda defines five research priorities. A structured midpoint assessment was needed to map the recent evidence base, characterize how that evidence is distributed across priorities, and identify gaps to guide the second half of the priority cycle. LITERATURE SEARCH: A scoping review was conducted and reported in accordance with PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews) guidelines. PubMed®, CINAHL Plus®, and Scopus® were searched for oncology nursing literature published between January 1, 2023, and June 30, 2025, using a Population-Concept-Context framework restricted to nursing journal or nurse-focused literature. All five priorities were mapped. Subconcept-level search blocks were built for three (precision symptom science, cancer care delivery and workforce sustainability, and environmental influences on cancer outcomes); patient navigation was searched with a single targeted block, and innovative research methodologies were charted as a cross-cutting characteristic of included studies. DATA EVALUATION: Of 3,973 database records identified, 1,685 were screened after duplicate removal and 444 underwent full-text review; with 84 records identified through artificial intelligence-assisted literature discovery and citation searching, 395 studies were charted in the narrative synthesis. A single reviewer screened all records; one or two additional reviewers with domain expertise then verified the included studies and their charting, and conducted the synthesis. SYNTHESIS: Midpoint evidence is concentrated in digital symptom science and unevenly distributed across priorities, indicating where oncology nursing research investment is most needed before the 2027 cycle. IMPLICATIONS FOR PRACTICE: Evidence was distributed unevenly across the five priorities. Precision symptom science was the most developed, with a substantial body of work on remote symptom monitoring, electronic patient-reported outcomes, and technology-enabled symptom self-management, although omics-based and biomarker-linked symptom science and the prospective clinical deployment of artificial intelligence remained at an early stage. Cancer care delivery and workforce sustainability showed moderate development: Workforce strain, burnout, retention, and resilience were consistently characterized, whereas outcome evidence for telehealth and home-based oncology care was comparatively sparse and methodologically uneven. Environmental influences on cancer outcomes were the least developed, with the strongest evidence linking poverty and area deprivation to symptom burden and access, whereas climate-related care disruption and cancer misinformation were addressed largely through descriptive, foundational, or practice-guidance literature rather than tested nursing interventions. Patient navigation and innovative research methodologies were represented by smaller, emergent bodies of work.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Oncology NursingSocieties, NursingNursing ResearchEvidence-Based NursingHumans

Stichwörter der Autor:innen

care deliverydigital monitoringenvironmental influencesequitysymptom science

Autor:innen und Institutionen

  • Jennifer Ross Majumdar.
  • Tara A. Albrecht.
  • Sarah M. Belcher.
  • Marlee Clark.
  • Meredith H. Cummings.
  • Claire Han.

Förderung

  • NCI NIH HHS

Zitieren

APA

Majumdar, J. R., Albrecht, T. A., Belcher, S. M., Clark, M., Cummings, M. H., Han, C., Linder, L. A., Nwozichi, C., Ruiz, R. O. S., Song, L., Springer, N. G., & Rosenzweig, M. Q. (2026). A Scoping Review of Recent Evidence Relevant to the Oncology Nursing Society 2024–2027 Research Agenda. Oncology Nursing Forum, 53(6). https://doi.org/10.1188/26.onf.e26535396

Vancouver

Majumdar JR, Albrecht TA, Belcher SM, Clark M, Cummings MH, Han C, et al. A Scoping Review of Recent Evidence Relevant to the Oncology Nursing Society 2024–2027 Research Agenda. Oncology Nursing Forum. 2026;53(6). doi:10.1188/26.onf.e26535396

BibTeX
@article{Majumdar2026,
  author = {Majumdar, Jennifer Ross and Albrecht, Tara A and Belcher, Sarah M and Clark, Marlee and Cummings, Meredith H and Han, Claire and Linder, Lauri A and Nwozichi, Chinomso and Ruiz, Rosalynn Ofel Sanchez and Song, Lixin and Springer, Natalia Gondim and Rosenzweig, Margaret Quinn},
  title = {A Scoping Review of Recent Evidence Relevant to the Oncology Nursing Society 2024–2027 Research Agenda},
  journal = {Oncology Nursing Forum},
  year = {2026},
  volume = {53},
  number = {6},
  doi = {10.1188/26.onf.e26535396}
}
Kostenlos starten →